Mensing H
Infection. 1986;14 Suppl 3:S217-8. doi: 10.1007/BF01667848.
In a microbiologically controlled, open study the 4-quinolone derivative enoxacin was tested in 51 patients suffering from infectious dermatoses. Clinical cure or improvement was observed in 91% of the patients, microbiological cure occurred in 65%. According to the results of our trial enoxacin is recommended as a therapeutic alternative, especially for the treatment of dermatitis caused by gram-negative bacilli.
在一项微生物学控制的开放性研究中，对51例患有感染性皮肤病的患者进行了4-喹诺酮衍生物依诺沙星的测试。91%的患者观察到临床治愈或改善，65%的患者实现了微生物学治愈。根据我们的试验结果，推荐依诺沙星作为一种治疗选择，特别是用于治疗由革兰氏阴性杆菌引起的皮炎。
